Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Perspective Therapeutics (CATX) Current Leases (2019 - 2025)

Perspective Therapeutics' Current Leases history spans 7 years, with the latest figure at $704000.0 for Q3 2025.

  • For Q3 2025, Current Leases fell 22.04% year-over-year to $704000.0; the TTM value through Sep 2025 reached $704000.0, down 22.04%, while the annual FY2024 figure was $957000.0, 1980.43% up from the prior year.
  • Current Leases for Q3 2025 was $704000.0 at Perspective Therapeutics, down from $847000.0 in the prior quarter.
  • Across five years, Current Leases topped out at $980000.0 in Q1 2025 and bottomed at $46000.0 in Q4 2023.
  • The 5-year median for Current Leases is $270000.0 (2022), against an average of $441166.7.
  • The largest YoY upside for Current Leases was 1980.43% in 2024 against a maximum downside of 54.29% in 2024.
  • A 5-year view of Current Leases shows it stood at $260000.0 in 2021, then rose by 4.62% to $272000.0 in 2022, then crashed by 83.09% to $46000.0 in 2023, then surged by 1980.43% to $957000.0 in 2024, then dropped by 26.44% to $704000.0 in 2025.
  • Per Business Quant, the three most recent readings for CATX's Current Leases are $704000.0 (Q3 2025), $847000.0 (Q2 2025), and $980000.0 (Q1 2025).